Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77369524)
Watch
English
The IL2 pathway in clinical immunosuppression
scientific article published on 01 November 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
title
The IL2 pathway in clinical immunosuppression
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
author name string
B Nashan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
publication date
1 November 2001
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
published in
Transplantation Proceedings
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
volume
33
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
issue
7-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
page(s)
3072-3074
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
cites work
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The temporal profile of calcineurin inhibition by cyclosporine in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relevant targets for therapy with monoclonal antibodies in allograft transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A humanized antibody that binds to the interleukin 2 receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disposition and immunodynamics of basiliximab in liver allograft recipients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized t
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A population pharmacokinetic screen to identify demographic-clinical covariates of basiliximab in liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of Certican (everolimus, rad) in the many pathways of chronic rejection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Steroid withdrawal in renal transplant recipients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0041-1345%2801%2902310-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0041-1345(01)02310-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
PubMed publication ID
11750321
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11750321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
